NEW YORK (GenomeWeb News) – Sequenom today released preliminary financial results for the fourth quarter and full-year 2014, projecting $37 million in fourth-quarter revenue and $151 million in annual revenue.

The revenue projection falls short of analyst estimates of $45 million for the quarter and $161 million for the year.

Sequenom disclosed the preliminary financial results on its website ahead of its presentation at the JP Morgan Healthcare Conference later this week.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.